An mRNA-based workflow validating neo-epitope presentation through HLA-I/peptide affinity purification
{{output}}
Presentation of human leukocyte antigen (HLA)-class I-restricted neo-epitopes is key for inducing an adaptive cytotoxic T-lymphocyte response against cancer. Validating presentation of these cancer-specific neo-epitopes following delivery to antigen-presenting... ...
